In this episode, we delve into the dramatic events surrounding 23andMe as it files for Chapter Eleven bankruptcy, while co-founder Anne Wojcicki steps down to pursue an independent bid. The discussion highlights the company's tumultuous journey, from plummeting market values to navigating the aftermath of a major cyberattack, all while striving to maintain its core mission of making genetic insights accessible.